Product NDC: | 0009-3073 |
Proprietary Name: | Depo-Medrol |
Non Proprietary Name: | METHYLPREDNISOLONE ACETATE |
Active Ingredient(s): | 40 mg/mL & nbsp; METHYLPREDNISOLONE ACETATE |
Administration Route(s): | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-3073 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011757 |
Marketing Category: | NDA |
Start Marketing Date: | 19590528 |
Package NDC: | 0009-3073-22 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-3073-22) > 1 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0009-3073-22 |
Proprietary Name | Depo-Medrol |
Package Description | 1 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-3073-22) > 1 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0009-3073 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | METHYLPREDNISOLONE ACETATE |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE |
Start Marketing Date | 19590528 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | METHYLPREDNISOLONE ACETATE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |